middle.news

How IDT Australia’s 40.6% Revenue Surge Masks Rising $8M Loss

9:13pm on Friday 29th of August, 2025 AEST Pharmaceuticals
Read Story

How IDT Australia’s 40.6% Revenue Surge Masks Rising $8M Loss

9:13pm on Friday 29th of August, 2025 AEST
Key Points
  • Revenue up 40.6% to $19.86 million driven by Advanced Therapies and disbursements
  • Net loss increased 49% to $8.06 million, including $1.2 million in bad debts
  • Facility utilisation improved from 5% to 35% over three years under Rebuild Strategy
  • New $20 million asset-based loan facility secured; previous NAB loan cancelled
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Idt Australia (ASX:IDT)
OPEN ARTICLE